Humacyte, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US44486Q1031
USD
1.30
0.04 (3.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
0.00
0.00
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
0.00
0.00
0.00
0.00
0.00
Raw Material Cost
7.19
7.72
8.26
8.28
8.43
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
9.28
6.60
6.20
4.35
2.20
Selling and Distribution Expenses
18.61
15.78
14.63
12.85
3.58
Other Expenses
7.93
7.00
5.71
5.70
5.19
Total Expenditure (Excl Depreciation)
114.40
100.05
86.14
82.47
66.09
Operating Profit (PBDIT) excl Other Income
-114.39999999999999
-100
-86.1
-82.5
-66.10000000000001
Other Income
4.10
8.57
4.19
1.28
1.77
Operating Profit (PBDIT)
-103.10
-83.75
-73.69
-72.91
-55.89
Interest
9.28
6.60
6.20
4.35
2.20
Exceptional Items
-29.13
-12.70
76.18
59.06
0.00
Gross Profit (PBDT)
-7.19
-7.72
-8.26
-8.28
-8.43
Depreciation
7.19
7.72
8.26
8.28
8.43
Profit Before Tax
-148.70
-110.78
-11.96
-26.48
-66.52
Tax
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-148.70
-110.78
-11.96
-26.48
-66.52
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
-148.70
-110.78
-11.96
-26.48
-66.52
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-148.70
-110.78
-11.96
-26.48
-66.52
Equity Capital
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
Reserves
-52.67
13.55
116.93
122.17
-350.32
Earnings per share (EPS)
-1.26
-1.07
-0.12
-0.66
-11.43
Diluted Earnings per share
-1.26
-1.07
-0.12
-0.66
-11.43
Operating Profit Margin (Excl OI)
0.0%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
0.0%
0.0%
0.0%
0.0%
0.0%
PAT Margin
0.0%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -34.21% vs -823.33% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -16.14% vs -18.49% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 40.91% vs 6.45% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Humacyte, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
0.00
27.12
-27.12
-100.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.00
27.12
-27.12
-100.00%
Raw Material Cost
7.19
30.97
-23.78
-76.78%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
75.18
-75.18
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
9.28
63.74
-54.46
-85.44%
Selling and Distribution Expenses
18.61
38.79
-20.18
-52.02%
Other Expenses
7.93
0.27
7.66
2,837.04%
Total Expenditure (Excl Depreciation)
114.40
211.39
-96.99
-45.88%
Operating Profit (PBDIT) excl Other Income
-114.40
-184.27
69.87
37.92%
Other Income
4.10
14.55
-10.45
-71.82%
Operating Profit (PBDIT)
-103.10
-157.09
53.99
34.37%
Interest
9.28
63.74
-54.46
-85.44%
Exceptional Items
-29.13
-3.66
-25.47
-695.90%
Gross Profit (PBDT)
-7.19
-3.85
-3.34
-86.75%
Depreciation
7.19
12.64
-5.45
-43.12%
Profit Before Tax
-148.70
-237.13
88.43
37.29%
Tax
0.00
2.43
-2.43
-100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-148.70
-239.56
90.86
37.93%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-148.70
-239.56
90.86
37.93%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-148.70
-239.56
90.86
37.93%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
-52.67
-6.75
-45.92
-680.30%
Earnings per share (EPS)
-1.26
-4.92
3.66
74.39%
Diluted Earnings per share
-1.26
-4.92
3.66
74.39%
Operating Profit Margin (Excl OI)
0.00%
-679.50%
0.00
679.50%
Gross Profit Margin
0.00%
-827.78%
0.00
827.78%
PAT Margin
0.00%
-883.35%
0.00
883.35%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Markets Mojo
No Net Sales in the last few periods
Annual - Consolidate Net Profit
Consolidate Net Profit -14.87 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -34.21% vs -823.33% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -10.72 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -16.14% vs -18.49% in Dec 2023

Annual - Interest
Interest 0.93 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 40.91% vs 6.45% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Markets Mojo
No Operating Profit Margin (Excl OI) in the last few periods